Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of EuBiologics.

    Client Virtual Booth

    EUBIOLOGICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    EuBiologics
    korearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    Building 8F, Dosan-daero 207beon-gil, Gangnam-gu, Seoul
    Telephone
    Telephone
    033-817-4001
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.eubiologics.com/kor/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics

    Details:

    The agreement aims to produce cholera vaccines including, Euvichol, an oral cholera vaccine for the prevention of cholera, a disease that is prevalent mainly in the developing countries.


    Lead Product(s): Euvichol

    Therapeutic Area: Infections and Infectious Diseases Product Name: Euvichol

    Highest Development Status: ApprovedProduct Type: Vaccine

    Recipient: GC Biopharma

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement August 28, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    POP Biotechnologies and EuBiologics' EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial

    Details:

    EuCorVac-19, a recombinant protein vaccine displaying the SARS-CoV-2 receptor-binding domain (RBD) antigen on the immunogenic liposomes, which is present top line interim results of a Phase 3 clinical trial.


    Lead Product(s): EuCorVac-19

    Therapeutic Area: Infections and Infectious Diseases Product Name: EuCorVac-19

    Highest Development Status: Phase IIIProduct Type: Vaccine

    Recipient: POP Biotechnologies

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 14, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    EuBiologics: Phase III Clinical Trial IND Approval of EuCorVac-19, COVID-19 Vaccine Candidate, in South Korea

    Details:

    Eubiologics is developing EuCorVac-19, its vaccine platform, which consists of owned antigen, EulMT in-licensed from Korea Institute of Science and Technology and SNAP technology of POP Biotechnologies that EuBiologics has invested.


    Lead Product(s): EuCorVac-19

    Therapeutic Area: Infections and Infectious Diseases Product Name: EuCorVac-19

    Highest Development Status: Phase I/ Phase IIProduct Type: Vaccine

    Partner/Sponsor/Collaborator: Korea Institute of Science and Technology

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable February 03, 2022

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of 'EuCorVac-19' in Korea

    Details:

    The EuCorVac-19 under development is a safe vaccine formulated with the coronavirus spike protein using recombinant protein technology and with a potent adjuvant.


    Lead Product(s): EuCorVac-19

    Therapeutic Area: Infections and Infectious Diseases Product Name: EuCorVac-19

    Highest Development Status: Phase IProduct Type: Vaccine

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable January 21, 2021

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search